Our previous study suggested that tumor-suppressive Klf4 undergoes mesenchymal epithelial transition (MET) and reduces the capability for migration, invasion, and lung metastasis in mesenchymal-like cells [20]. The gene discussed is KLF4; the disease is neoplasm.